Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial
K Wanaratna, P Leethong, N Inchai, W Chueawiang… - MedRxiv, 2021 - medrxiv.org
Objectives To assess the efficacy and safety of Andrographis paniculata extract (APE) in
adults with mild COVID-19. Methods Sixty-three adults aged 18-60 years, without co-morbidity, …
adults with mild COVID-19. Methods Sixty-three adults aged 18-60 years, without co-morbidity, …
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial (preprint)
K Wanaratna, P Leethong, N Inchai, W Chueawiang… - 2021 - pesquisa.bvsalud.org
Objective: To assess the efficacy and safety of Andrographis paniculata extract (APE) in adults
with mild COVID-19. Methods: The alcoholic extract of the aerial part of A. paniculata was …
with mild COVID-19. Methods: The alcoholic extract of the aerial part of A. paniculata was …
[PDF][PDF] Inflammatory cytokines and metabolite changes after high dose of Andrographis paniculata extract: a preliminary study in mild COVID-19 case patients
…, K Wanaratna, N Inchai, W Chueawiang… - Journal of Basic and …, 2021 - researchgate.net
The Coronavirus disease which began in 2019 (COVID-19) was declared a global pandemic.
It can increase inflammatory cytokines leading to organ failure. Efforts are being made to …
It can increase inflammatory cytokines leading to organ failure. Efforts are being made to …
